Market revenue in 2022 | USD 371.2 million |
Market revenue in 2030 | USD 891.1 million |
Growth rate | 11.6% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polyvinyl Chloride (PVC) |
Historical data | 2019 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 22.36% in 2022. Horizon Databook has segmented the Japan biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
The biopharma plastics market in Japan is expected to witness high growth over the forecast period on account of increasing demand in biopharma applications. Moreover, increasing healthcare cost on account of expensive and innovative treatments are expected to drive the demand for biopharma plastics over the forecast period.
Increasing incidence of chronic diseases has led to higher healthcare costs and need for biopharma applications including protective wear and syringes, positively impacting the biopharma plastics market. According to health policy studies of the Organization for Economic Co-operation and Development (OECD), Japan has the highest life expectancy of 83.9 years among OECD countries.
This implies a higher risk of COVID-19 for elderly citizens in Japan. Furthermore, the global death rate of older people (60 years and above) is higher, putting the older population in Japan at high risk. Thus, the demand for biopharma plastics equipment is expected to be high, which, in return, is expected to drive the biopharma plastics market demand over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into Japan biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account